Products Categories
CAS No.: | 56776-01-3 |
---|---|
Name: | Tulobuterol hydrochloride |
Article Data: | 1 |
Molecular Structure: | |
Formula: | C12H19Cl2NO |
Molecular Weight: | 264.195 |
Synonyms: | Benzenemethanol,2-chloro-a-[[(1,1-dimethylethyl)amino]methyl]-,hydrochloride (9CI);Atenos;Berachin;Brelomax;Bremax;C 78;Chlibamol;Hokunalin;Lobuterol;Respacal; |
EINECS: | 634-677-4 |
Density: | 1.098 g/cm3 |
Melting Point: | 163oC |
Boiling Point: | 338.2 °C at 760 mmHg |
Flash Point: | 158.3 °C |
Solubility: | Soluble in methanol or water. |
Appearance: | Appearance White crystalline powder |
Hazard Symbols: | Xn |
Risk Codes: | 22 |
PSA: | 32.26000 |
LogP: | 3.95440 |
What can I do for you?
Get Best Price
The IUPAC name of alpha-(tert-Butylamino)methyl-2-chloro-benzyl alcohol hydrochloride is 2-(tert-butylamino)-1-(2-chlorophenyl)ethanol hydrochloride. With the CAS registry number 56776-01-3, it is also named as Tulobuterol hydrochloride. The product's category is Active Pharmaceutical Ingredients. It is highly toxic. When heated to decomposition it emits very toxic fumes of Cl− and NOx. So the storage environment should be well- ventilated, low-temperature and dry. Keep this chemical separate from raw materials of food.
The other characteristics of alpha-(tert-Butylamino)methyl-2-chloro-benzyl alcohol hydrochloride can be summarized as: (1)ACD/LogP: 2.53; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): -0.45; (4)ACD/LogD (pH 7.4): 0.85; (5)ACD/BCF (pH 5.5): 1; (6)ACD/BCF (pH 7.4): 1.04; (7)ACD/KOC (pH 5.5): 1; (8)ACD/KOC (pH 7.4): 11.98; (9)#H bond acceptors: 2; (10)#H bond donors: 2; (11)#Freely Rotating Bonds: 5; (12)Flash Point: 158.3 °C; (13)Enthalpy of Vaporization: 61.38 kJ/mol; (14)Boiling Point: 338.2 °C at 760 mmHg; (15)Vapour Pressure: 3.9E-05 mmHg at 25°C; (16)Rotatable Bond Count: 4; (17)Exact Mass: 263.08437; (18)MonoIsotopic Mass: 263.08437; (19)Topological Polar Surface Area: 32.3; (20)Heavy Atom Count: 16; (21)Complexity: 191.
People can use the following data to convert to the molecule structure.
1. SMILES:[Cl-].Clc1ccccc1C(O)C[NH2+]C(C)(C)C
2. InChI:InChI=1/C12H18ClNO.ClH/c1-12(2,3)14-8-11(15)9-6-4-5-7-10(9)13;/h4-7,11,14-15H,8H2,1-3H3;1H
3. InChIKey:RSLNRVYIRDVHLY-UHFFFAOYAD
The following are the toxicity data which has been tested.
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
dog | LD50 | intravenous | 45mg/kg (45mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS | Arzneimittel-Forschung. Drug Research. Vol. 25, Pg. 1028, 1975. |
dog | LD50 | oral | 300mg/kg (300mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: ATAXIA GASTROINTESTINAL: NAUSEA OR VOMITING | Arzneimittel-Forschung. Drug Research. Vol. 27, Pg. 1439, 1977. |
dog | LD50 | subcutaneous | 150mg/kg (150mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 25, Pg. 1028, 1975. | |
mouse | LD50 | intraperitoneal | 76mg/kg (76mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS | Arzneimittel-Forschung. Drug Research. Vol. 25, Pg. 1028, 1975. |
mouse | LD50 | intravenous | 40mg/kg (40mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS | Arzneimittel-Forschung. Drug Research. Vol. 25, Pg. 1028, 1975. |
mouse | LD50 | oral | 243mg/kg (243mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS | Arzneimittel-Forschung. Drug Research. Vol. 25, Pg. 1028, 1975. |
mouse | LD50 | subcutaneous | 121mg/kg (121mg/kg) | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 12, Pg. 933, 1981. | |
rabbit | LD50 | intravenous | 20mg/kg (20mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: DYSPNEA BEHAVIORAL: EXCITEMENT | Arzneimittel-Forschung. Drug Research. Vol. 27, Pg. 1439, 1977. |
rabbit | LD50 | oral | 525mg/kg (525mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS | Arzneimittel-Forschung. Drug Research. Vol. 25, Pg. 1028, 1975. |
rabbit | LD50 | subcutaneous | 164mg/kg (164mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 25, Pg. 1028, 1975. | |
rat | LD50 | intraperitoneal | 104mg/kg (104mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS | Arzneimittel-Forschung. Drug Research. Vol. 25, Pg. 1028, 1975. |
rat | LD50 | intravenous | 42mg/kg (42mg/kg) | LUNGS, THORAX, OR RESPIRATION: CHRONIC PULMONARY EDEMA LIVER: OTHER CHANGES | Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 23, Pg. 1107, 1981. |
rat | LD50 | oral | 560mg/kg (560mg/kg) | Drugs in Japan Vol. -, Pg. 766, 1995. | |
rat | LD50 | subcutaneous | 349mg/kg (349mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 25, Pg. 1028, 1975. |